Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 3

In campaign 1, 124.3 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared in 2 stages from 5-bromo-2-methylpyridine. The first stage was a regioselective copper-catalyzed Ullmann reaction using 1H-1,2,3-triazole. The second stage was an oxidation with peracetic acid to form the corresponding pyridine N-oxide. In campaign 2, 223.8 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared. An alternative palladium-catalyzed Buchwald−Hartwig approach using Me4tBuXPhos as a ligand was developed but not scaled up. 2-Methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.

Authors

Institutions

Publication Details

Journal
Organic Process Research & Development
Published
2026-11-18
DOI
https://doi.org/10.1021/acs.oprd.6c00298
Citations
3
Primary Topic
Catalytic Cross-Coupling Reactions
Type
article
Field-Weighted Citation Impact
3.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 3

Jonathan C. Churchill, Paul Leong, John S Carey
3 citations
Organic Process Research & Development
Catalytic Cross-Coupling Reactions
3.78
article

Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 3

Jonathan C. Churchill, Paul Leong, John S Carey
article en
3 citations

Abstract

In campaign 1, 124.3 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared in 2 stages from 5-bromo-2-methylpyridine. The first stage was a regioselective copper-catalyzed Ullmann reaction using 1H-1,2,3-triazole. The second stage was an oxidation with peracetic acid to form the corresponding pyridine N-oxide. In campaign 2, 223.8 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared. An alternative palladium-catalyzed Buchwald−Hartwig approach using Me4tBuXPhos as a ligand was developed but not scaled up. 2-Methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.

Organic Process Research & Development
The Priory Hospital (GB), Lonza (Switzerland) (CH)
Openalex Percentile: Top 9%
Catalytic Cross-Coupling Reactions
3.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon